* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Immuno-Biological Laboratories Co Days Payable Chart
TSE:4570 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Immuno-Biological Laboratories Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Immuno-Biological Laboratories Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Immuno-Biological Laboratories Co's Days Payable falls into.
Immuno-Biological Laboratories Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Immuno-Biological Laboratories Co (TSE:4570) has a Days Payable of 6.25 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Immuno-Biological Laboratories Co and its competitors. This is near median its historical median of 6.05. Over the past decade, Immuno-Biological Laboratories Co's Days Payable has ranged from 4.11 to 8.72. According to the industry distribution chart, Immuno-Biological Laboratories Co ranks #690 out of 700 companies in the Biotechnology industry, placing it in the top 98.6%.
Is Immuno-Biological Laboratories Co's Days Payable too high?
Immuno-Biological Laboratories Co's current Days Payable of 6.25 is near median its 10-year median of 6.05. Over the past 10 years, this metric has ranged from a low of 4.11 to a high of 8.72. The Biotechnology industry median Days Payable is 113.10. Immuno-Biological Laboratories Co's value of 6.25 is 94.5% below this industry median. Based on the distribution chart, Immuno-Biological Laboratories Co ranks #690 out of 700 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Immuno-Biological Laboratories Co has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Immuno-Biological Laboratories Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Immuno-Biological Laboratories Co ranks #690 out of 700 companies for Days Payable. This places Immuno-Biological Laboratories Co in the lower half of its industry. The industry median Days Payable is 113.10. Immuno-Biological Laboratories Co's value of 6.25 is 94.5% below this benchmark. Historically, Immuno-Biological Laboratories Co's own Days Payable has ranged from 4.11 to 8.72 over the past decade. While the company's 10-year median is 6.05 vs. the industry median of 113.10, Immuno-Biological Laboratories Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Immuno-Biological Laboratories Co's current Days Payable of 6.25 is 94.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Immuno-Biological Laboratories Co and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Immuno-Biological Laboratories Co's current Days Payable is 6.25, which is near median its own 10-year median of 6.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immuno-Biological Laboratories Co stock overvalued right now?
Based on GuruFocus' analysis, Immuno-Biological Laboratories Co (TSE:4570) is currently considered Significantly Overvalued. The stock's GF Value™ is 円577.92, compared to a current price of 円1,009.00 — trading 74.6% above its estimated fair value. The current Days Payable is 6.25, which is near median its 10-year median of 6.05 and 94.5% below the Biotechnology industry median of 113.10. Immuno-Biological Laboratories Co's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Immuno-Biological Laboratories Co (TSE:4570), the current Days Payable is 6.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Immuno-Biological Laboratories Co (TSE:4570) Overvalued in 2026?
Based on GuruFocus' analysis, Immuno-Biological Laboratories Co stock appears to be overvalued.
The current stock price of 円1,009.00 is trading 74.6% above its estimated GF Value™ of 円577.92.
GuruFocus considers Immuno-Biological Laboratories Co to be Significantly Overvalued.
Key valuation signals for TSE:4570:
Days Payable: 6.25 (near median its 10-year median of 6.05)
GF Value™: 円577.92 vs. price of 円1,009.00 (74.6% above fair value)
Industry Position: 94.5% below the Biotechnology median (#690 of 700)
No single metric tells the full story. See the TSE:4570 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Immuno-Biological Laboratories Co Business Description
Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.
59GF Score
Get the complete analysis for TSE:4570
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4570 has been successfully added to your 
